Simplex Trading, LLC Oramed Pharmaceuticals Inc. Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

A detailed history of Simplex Trading, LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 75 shares of ORMP stock, worth $180. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$180

% of portfolio

0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$2.07 - $2.83 $155 - $212	75 New	75 $0
Q3 2023 Nov 01, 2023	SELL	$2.51 - $3.55 $9,036 - $12,780	-3,600 Reduced 59.06%	2,496 $6,000
Q2 2023 Aug 04, 2023	BUY	$2.12 - $4.47 $12,923 - $27,249	6,096 New	6,096 $21,000
Q4 2022 Feb 02, 2023	SELL	$5.88 - $12.03 $28,171 - $57,635	-4,791 Reduced 11.09%	38,427 $462,000
Q3 2022 Nov 04, 2022	BUY	$4.6 - $9.91 $105,132 - $226,493	22,855 Added 112.24%	43,218 $280,000
Q2 2022 Aug 03, 2022	BUY	$3.72 - $9.0 $75,750 - $183,267	20,363 New	20,363 $93,000
Q1 2022 May 02, 2022	SELL	$8.19 - $13.89 $56,756 - $96,257	-6,930 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$12.98 - $29.75 $89,951 - $206,167	6,930 New	6,930 $98,000
Q4 2020 Feb 02, 2021	SELL	$2.48 - $4.64 $59,827 - $111,935	-24,124 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$2.58 - $4.16 $62,239 - $100,355	24,124 New	24,124 $62,000
Q1 2020 Apr 29, 2020	SELL	$2.6 - $5.5 $15,870 - $33,572	-6,104 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$2.43 - $5.74 $14,832 - $35,036	6,104 New	6,104 $31,000
Q3 2019 Oct 15, 2019	SELL	$2.88 - $3.96 $5,112 - $7,029	-1,775 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$2.88 - $4.36 $5,112 - $7,739	1,775 New	1,775 $6,000
Q1 2019 Apr 18, 2019	SELL	$2.95 - $3.64 $3,053 - $3,767	-1,035 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$3.0 - $4.94 $1,464 - $2,410	488 Added 89.21%	1,035 $3,000
Q3 2018 Oct 23, 2018	BUY	$4.64 - $7.11 $2,538 - $3,889	547 New	547 $2,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

6.37M

Call Options Held

Put Options Held

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $93.6M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account